Interstitial lung abnormalities
Incidental interstitial changes on CT and their significance.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 0, 0, 0, 0, 0.
All papers from the last 12 months
110 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Impact of Comorbid Interstitial Lung Abnormalities on Acute Exacerbations of COPD: A Hospital-Based Retrospective Cohort StudyCOPD2026 DecPMID 41704188
- Cumulative lifecourse cardiovascular health and interstitial lung abnormalitiesEur Respir J2026 Oct 15PMID 42880938
- Interstitial Lung Abnormalities: A Multidisciplinary Narrative ReviewSemin Respir Crit Care Med2026 Oct 12PMID 42863827
- Interstitial lung abnormalities and disease in World Trade Center workersOccup Med (Lond)2026 Oct 12PMID 42862115
- Predictive Model for Identifying Fibrotic Interstitial Lung Abnormalities on Computed Tomography for Respiratory SpecialistsRespirology2026 Oct 7PMID 42844158
- Incidence of and risk factors for immune checkpoint inhibitor-related pneumonitis in thoracic malignancies: a prospective multicenter studyOncologist2026 Oct 7PMID 42776614
- Contemporary Concise Review 2025: Interstitial Lung DiseaseRespirology2026 OctPMID 42706010Review
- Lung Cancer Screening: Beyond Pulmonary NodulesRadiographics2026 OctPMID 42690965Review
- Clinical and Imaging Features of Tepotinib-Induced Interstitial Lung Disease in the Post-Marketing Setting in JapanCancer Sci2026 OctPMID 42452783
- Cause of death in fibrotic and nonfibrotic interstitial lung abnormalities: the MESA studyAm J Respir Crit Care Med2026 Oct 1PMID 42446123
More pulmonology trends
All specialties →Antifibrotics in pulmonary fibrosis
Nintedanib, pirfenidone and newer antifibrotics.
Biologics in severe asthma
Biologic therapies for severe asthma.
Key point: Biologic choice in adult severe asthma can be impacted by quality of life impairment, lung function, exacerbation frequency, oral corticosteroid use, endotype, biomarkers and comorbidities.
Lung cancer screening
Low-dose CT screening for lung cancer.
Key point: Low-dose CT screening reduces lung cancer death risk by at least 21% and should be offered to people aged 50–75 with at least 20 pack-years.
E-cigarettes and the lungs
Respiratory effects of vaping and e-cigarettes.
Sotatercept
An activin signalling inhibitor for pulmonary arterial hypertension.
Ensifentrine
An inhaled PDE3/PDE4 inhibitor for COPD.
Key point: Ensifentrine significantly improved lung function, symptoms and quality of life versus placebo in Chinese individuals with COPD, with similar adverse event rates.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"interstitial lung abnormalit*"[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.